Significant altered metabolites induced by drugs that interfere with RNAa.
No. | RT/min | Biomarker | m/z | P value | AUC | FC | Trend | Metabolite pathway |
---|---|---|---|---|---|---|---|---|
1 | 39.952 | Ribonic acid | 167.0589 | ***P < 0.001 | 0.520 | 1.562 | ↑ | — |
2 | 12.269 | Deoxyadenosine | 274.1097 | ***P < 0.001 | 0.875 | 1.646 | ↑ | Purine metabolism |
3 | 12.759 | 5-Thymidylic acid | 340.2486 | **P < 0.01 | 0.843 | 6.795 | ↑ | Pyrimidine metabolism |
4 | 40.002 | Neryl glucoside | 345.0645 | **P < 0.01 | 0.807 | 0.004 | ↓ | — |
5 | 16.917 | Uracil | 113.0375 | **P < 0.01 | 0.521 | 1.011 | ↑ | Pyrimidine metabolism |
6 | 0.675 | Hypoxanthine | 136.9216 | ***P < 0.001 | 0.821 | 2.487 | ↑ | Pyrimidine metabolism |
7 | 12.983 | Isoleucine | 131.9327 | ***P < 0.001 | 0.912 | 3.769 | ↑ | Valine, leucine and isoleucine biosynthesis |
8 | 19.790 | Aspartic acid | 134.0478 | ***P < 0.001 | 0.615 | 0.411 | ↓ | Alanine, aspartate and glutamate metabolism |
9 | 19.792 | Dehydroalanine | 88.0386 | ***P < 0.001 | 0.812 | 1.856 | ↑ | Methylation metabolism |
10 | 11.429 | Dimethylglycine | 104.0691 | **P < 0.01 | 0.512 | 0.136 | ↓ | Methylation metabolism |
11 | 15.802 | N-Methyl-d-aspartic acid | 148.0639 | **P < 0.01 | 0.735 | 0.021 | ↓ | — |
12 | 1.795 | N-Acetyl-d-glucosamine 6-phosphate | 319.0641 | ***P < 0.001 | 0.631 | 0.106 | ↓ | Amino sugar and nucleotide sugar metabolism |
“↑” indicates that the metabolite content in the drug-treated group is higher than that in the control group; “↓” indicates that the metabolite content in the drug-treated group is lower than that in the control group; the P value was calculated using One Way ANOVA with the Bonferroni correction (significance at *P < 0.05, **P < 0.01, ***P < 0.001); “—” means that there is no corresponding metabolite pathway determined by MetaboAnalyst 3.0.